✦ LIBER ✦

Rationale for targeted therapies in hepatocellular carcinoma

✍ Scribed by Sandrine Faivre; Chantal Dreyer; Ghassan El Maalouf; Marie-Paule Sablin; Eric Raymond

Book ID: 107384319
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 3
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-008-0079-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular targeted therapies in hepatoce

Molecular targeted therapies in hepatocellular carcinoma

✍ Josep M. Llovet; Jordi Bruix 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. There is evidence of aberrant activation of several signaling cascades such as epidermal growth factor receptor (EGFR), Ras/extracellular signal-regulated kinase, phosphoinositol 3-kinase/mammalian

Molecularly targeted therapy for hepatoc

Molecularly targeted therapy for hepatocellular carcinoma

✍ Shinji Tanaka; Shigeki Arii 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

Molecular targeted therapy for hepatocel

Molecular targeted therapy for hepatocellular carcinoma

✍ Melanie Thomas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 150 KB

Molecularly targeted therapy in hepatoce

Molecularly targeted therapy in hepatocellular carcinoma

✍ Hung Huynh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Molecular targeted therapy for advanced

Molecular targeted therapy for advanced hepatocellular carcinoma

✍ Ying Chun Shen; Chiun Hsu; Ann Lii Cheng 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

New therapies for hepatocellular carcino

New therapies for hepatocellular carcinoma

✍ Avila, M A; Berasain, C; Sangro, B; Prieto, J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 378 KB